3C-BOH
3C-BOH, also known as β-methoxy-3,4-methylenedioxyamphetamine (β-methoxy-MDA) or as BOMDA, is a psychoactive drug of the phenethylamine, amphetamine, MDxx, and BOx families related to 3,4-methylenedioxyamphetamine (MDA).
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
3C-BOH, also known as β-methoxy-3,4-methylenedioxyamphetamine (β-methoxy-MDA) or as BOMDA, is a psychoactive drug of the phenethylamine, amphetamine, MDxx, and BOx families related to 3,4-methylenedioxyamphetamine (MDA). It is the β-methoxy derivative of MDA and the amphetamine (α-methyl) analogue of BOH (β-methoxy-MDPEA).
The drug is active at a dose of 40 to 70 mg orally with a duration of 3 to 6 hours. It is said to produce "amphetamine-like effects", as well as physical side effects and temporary body stiffness.
3C-BOH acts as a monoamine releasing agent and reuptake inhibitor, including of serotonin and norepinephrine, and additionally acts as an agonist of the serotonin 5-HT 2 receptors, among other actions. The compound can exist as four stereoisomers, with individual assessment of each individual isomer still needed.
3C-BOH was first described in the scientific literature by Daniel Trachsel and colleagues in 2013 via personal communication with another person.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1358380104 under CC BY-SA 4.0; modifications have been made.